Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Close this search box.


Our Discovery Services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development. In Small Molecules, our services cover Chemistry, Biology, Safety Assessment & Toxicology, and Computational & Data Sciences. In Biologics, our services cover recombinant DNA engineering, cell line development, hybridoma technology, Next-Generation Sequencing, and protein sciences (purification & crystallography).

What sets us apart in Discovery Services, is our ability to seamlessly connect discovery and development, our target-focused modality, and therapeutic area – agnostic approach. In addition, is our collaborative partnership model, supported by robust logistics, streamlined project management, and cutting-edge IT infrastructure.

We started our Discovery servies in 1994, as a resource for synthetic chemistry. Today, our world-class chemistry team provides a diverse range of platform capabilities across Synthetic and Medicinal Chemistry, Library Synthesis, Analytical Support, and Purification. We bring to the table deep expertise in PROTACs, Antibody-Drug Conjugates (ADCs), Peptides, Nucleotides, and Carbohydrates.

Our rapidly expanding Discovery Biology team works on cutting-edge research across Cell Engineering, Antibody Discovery, Protein Sciences, Assay Biology, In vivo Pharmacology, and Genomics and Translational sciences. We also offer a full DMPK suite, both in vitro ADME and in vivo PK studies.

Our Safety Assessment team offers both exploratory studies as well as full GLP packages. We also offer specialty studies such as In vitro Cytotoxicity, Skin Irritation, Phototoxicity, Skin Sensitization, as well as Medical Devices Testing.

All our Discovery Services are supported by advanced informatics capabilities that enable faster, more efficient decision making. Our Computational & Data Sciences capabilities extend across Target Intelligence, Multi-Omics Data Analysis, Systems Modelling, Molecular Modelling, Drug Repurposing, Predictive Modelling, and Multiparameter Optimization.

We have a proven track record of being able to scale strategic partnerships, and offer flexible business models with cost-effective operations and accelerated R&D timescales, benchmarked to industry gold standards.

Discovery Services For Small Molecules

Discovery Chemistry
Discovery Biology
Safety Assessment
Computational & Data Sciences

Discovery Services For Biologics

Molecular Biology
Protein Sciences
Cell Line Development & Analysis
Antibody Generation

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details